Zhong HJ - Search Results

1

Targeting PGAM1 in cancer: An emerging therapeutic opportunity.

Yang GJ, Tao F, Zhong HJ, Yang C, Chen J. Yang GJ, et al. Among authors: zhong hj. Eur J Med Chem. 2022 Dec 15;244:114798. doi: 10.1016/j.ejmech.2022.114798. Epub 2022 Oct 3. Eur J Med Chem. 2022. PMID: 36215859 Review.

2

Anticancer osmium complex inhibitors of the HIF-1α and p300 protein-protein interaction.

Yang C, Wang W, Li GD, Zhong HJ, Dong ZZ, Wong CY, Kwong DW, Ma DL, Leung CH. Yang C, et al. Among authors: zhong hj. Sci Rep. 2017 Feb 22;7:42860. doi: 10.1038/srep42860. Sci Rep. 2017. PMID: 28225008 Free PMC article.

3

Recent development of transition metal complexes with in vivo antitumor activity.

Liang JX, Zhong HJ, Yang G, Vellaisamy K, Ma DL, Leung CH. Liang JX, et al. Among authors: zhong hj. J Inorg Biochem. 2017 Dec;177:276-286. doi: 10.1016/j.jinorgbio.2017.06.002. Epub 2017 Jun 16. J Inorg Biochem. 2017. PMID: 28641893 Review.

4

Small Molecule Pin1 Inhibitor Blocking NF-κB Signaling in Prostate Cancer Cells.

Wu KJ, Zhong HJ, Yang G, Wu C, Huang JM, Li G, Ma DL, Leung CH. Wu KJ, et al. Among authors: zhong hj. Chem Asian J. 2018 Feb 2;13(3):275-279. doi: 10.1002/asia.201701216. Epub 2018 Jan 15. Chem Asian J. 2018. PMID: 29288531

5

Identification of a rhodium(iii) complex as a Wee1 inhibitor against TP53-mutated triple-negative breast cancer cells.

Yang GJ , Zhong HJ , Ko CN , Wong SY , Vellaisamy K , Ye M , Ma DL , Leung CH . Yang GJ , et al. Among authors: zhong hj. Chem Commun (Camb). 2018 Mar 6;54(20):2463-2466. doi: 10.1039/c7cc09384e. Chem Commun (Camb). 2018. PMID: 29367998

6

Selective Inhibition of Lysine-Specific Demethylase 5A (KDM5A) Using a Rhodium(III) Complex for Triple-Negative Breast Cancer Therapy.

Yang GJ, Wang W, Mok SWF, Wu C, Law BYK, Miao XM, Wu KJ, Zhong HJ, Wong CY, Wong VKW, Ma DL, Leung CH. Yang GJ, et al. Among authors: zhong hj. Angew Chem Int Ed Engl. 2018 Oct 1;57(40):13091-13095. doi: 10.1002/anie.201807305. Epub 2018 Jul 19. Angew Chem Int Ed Engl. 2018. PMID: 29968419

7

Structure-Based Discovery of a Selective KDM5A Inhibitor that Exhibits Anti-Cancer Activity via Inducing Cell Cycle Arrest and Senescence in Breast Cancer Cell Lines.

Yang GJ, Ko CN, Zhong HJ, Leung CH, Ma DL. Yang GJ, et al. Among authors: zhong hj. Cancers (Basel). 2019 Jan 15;11(1):92. doi: 10.3390/cancers11010092. Cancers (Basel). 2019. PMID: 30650517 Free PMC article.

8

Editorial: Epigenetics of the immune component of inflammation.

Liu YJ, Wang H, Zhong HJ, Chong CM, Yang GJ. Liu YJ, et al. Among authors: zhong hj. Front Immunol. 2022 Aug 22;13:1000836. doi: 10.3389/fimmu.2022.1000836. eCollection 2022. Front Immunol. 2022. PMID: 36072580 Free PMC article. No abstract available.

9

A Rhodium(III) Complex as an Inhibitor of Neural Precursor Cell Expressed, Developmentally Down-Regulated 8-Activating Enzyme with in Vivo Activity against Inflammatory Bowel Disease.

Zhong HJ, Wang W, Kang TS, Yan H, Yang Y, Xu L, Wang Y, Ma DL, Leung CH. Zhong HJ, et al. J Med Chem. 2017 Jan 12;60(1):497-503. doi: 10.1021/acs.jmedchem.6b00250. Epub 2016 Dec 23. J Med Chem. 2017. PMID: 27976900

10

An Iridium(III) Complex Inhibits JMJD2 Activities and Acts as a Potential Epigenetic Modulator.

Liu LJ, Lu L, Zhong HJ, He B, Kwong DW, Ma DL, Leung CH. Liu LJ, et al. Among authors: zhong hj. J Med Chem. 2015 Aug 27;58(16):6697-703. doi: 10.1021/acs.jmedchem.5b00375. Epub 2015 Aug 11. J Med Chem. 2015. PMID: 26225543

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page